Truist analyst Srikripa Devarakonda initiated coverage of Edgewise Therapeutics with a Buy rating.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EWTX:
Truist analyst Srikripa Devarakonda initiated coverage of Edgewise Therapeutics with a Buy rating.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EWTX: